The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis
|
|
- Isaac Arnold
- 5 years ago
- Views:
Transcription
1 The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis JAMES P. STEWART, JIM J. EGAN, ALAN J. ROSS, BRIAN G. KELLY, SHE S. LOK, PHILIP S. HASLETON, and ASHLEY A. WOODCOCK Department of Veterinary Pathology, The University of Edinburgh, Summerhall, Edinburgh; North West Lung Centre and Department of Histopathology, Wythenshawe Hospital, Manchester, United Kingdom Idiopathic pulmonary fibrosis (IPF) is a clinical syndrome in which the precipitating factors are unclear. An association between Epstein-Barr Virus (EBV) and IPF had previously been suggested using serology and immunohistochemistry. This study sought confirmation of the presence of EBV DNA in the lung tissue of patients with IPF. Lung tissue obtained surgically from 27 patients with IPF and 28 control subjects was investigated for the presence of EBV by immunohistochemistry and polymerase chain reaction () analysis. Immunohistochemistry used antibodies specific for EBV lytic cycle antigens (gp340/220 and VCA). Nested analysis used oligonucleotide primers specific for EBV and was sensitive to one copy of EBV DNA. Twelve of the 27 patients with IPF (44%) and three of the 28 control subjects (10%) were EBV positive by immunohistochemistry (p 0.005). Thirteen of the patients with IPF (48%) and four of the control subjects (14%) were EBV positive by (p 0.007). Eleven of the patients with IPF (41%) and none of the control subjects were EBV positive by both immunohistochemistry and (p 0.001). These data further suggest an association between EBV and IPF. In addition it defines a novel method for detecting EBV in lung tissue. EBV may be involved in the pathogenesis of the disease; however, further studies are required to establish a causal relationship. Stewart JP, Egan JJ, Ross AJ, Kelly BG, Lok SS, Hasleton PS, Woodcock AA. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. AM J RESPIR CRIT CARE MED 1999;159: Idiopathic pulmonary fibrosis (IPF) is a clinical syndrome characterized by clubbing, bibasal late inspiratory crackles, and reticular shadowing on chest radiographs. The causes of IPF are unclear. Environmental and infective factors have been implicated in the disease process; however, there is no clear causal association (1 3). The Epstein-Barr virus (EBV) is a ubiquitous Herpesvirus that has been associated with a number of diseases. These include B-cell lymphoproliferative disease, Burkitt s lymphoma, Hodgkin s disease, and nasopharyngeal carcinoma. Although normally associated with infection of the upper respiratory tract and B-lymphocytes, EBV both infects and replicates in the lower respiratory tract (4, 5). An association, based on serology between EBV infection and IPF, was made some years ago (6). Vergnon and colleagues (6) identified elevated immunoglobulin A (IgA) levels against (Received in original form July 15, 1998 and in revised form November 3, 1998) Supported by a grant from Glaxo/Wellcome Plc. Dr. Stewart is the recipient of a University Research Fellowship from the Royal Society. Dr. Lok is supported by the New Heart New Start Charity. Correspondence and requests for reprints should be addressed to James P. Stewart, Department of Veterinary Pathology, The University of Edinburgh, Edinburgh EH9 1QH, UK. Am J Respir Crit Care Med Vol 159. pp , 1999 Internet address: viral capsid antigen (VCA) in a study of 12 patients with IPF. In a recent report (7), we demonstrated productive EBV replication in type II alveolar epithelial cells in IPF by performing immunohistochemistry (IHC). Fourteen of 20 patients with biopsy-proven IPF had evidence of EBV lytic cycle antigen expression (VCA and gp340/220) in type II alveolar cells in comparison with two of 21 control subjects. However, it was felt that confirmatory evidence of the existence of EBV DNA within lung tissue was required. To test this hypothesis we have developed a sensitive EBV-specific nested assay. This study examined lung tissue from patients with IPF and a group of control subjects by IHC and analysis to determine the prevalence of EBV DNA and antigen expression in both groups. METHODS Patient Selection Twenty-seven archived, surgical lung biopsies were randomly selected for study. Lung tissue was fixed in buffered formalin. In each case, 5- M sections stained with hematoxylin-eosin were reviewed blind by the pulmonary histopathologist (PSH) in order to confirm a variegate pattern of fibrosis consistent with usual interstitial pneumonia (UIP) and to exclude nonspecific interstitial pneumonia (NSIP) and desquamative interstitial pneumonia. Corresponding clinical data were collected and assessed blind (SSL/JJE). Patients were designated as having IPF based on lung histology and a typical radiologic pattern on high resolution computer tomography (HRCT). On histology, a diagnosis of IPF was made if the biopsy met the following criteria. (1) A variegate
2 Stewart, Egan, Ross, et al.: Epstein-Barr DNA and IPF 1337 picture of interstitial fibrosis, inflammation, and normal tissue. (2) Tendency for fibrosis to subpleural and peripheral distribution. (3) Exclusion of features indicating other pathology, e.g., asbestos bodies and granulomas. HCRT was performed using a picker PQ scanner at 10- mm intervals with 1.5-mm sections using the long bone algorithm. Criteria for diagnosing IPF were as follows. (1) Symmetrical bilateral interstitial infiltrate. (2) Pulmonary infiltrate affecting the bases of the lung and distributed subpleurally. (3) Presence of honeycombing of the lung with a subpleural distribution. (4) A predominant picture of fibrosis. Patients who had undergone pneumonectomies or lung biopsies for other reasons were randomly selected as control subjects (n 28). All the tissue blocks were coded and sent to a separate laboratory (J.P.S., A.R., B.K.) for EBV studies. Eleven of the 27 patients with IPF and 16 of the 28 control subjects had been used in our previous study (7). These were as follows. Patients with IPF: Nos. 1 4, 6, 7, 11 13, 17, 18, and 20 (see Table 2). Control patients: Nos. 1 5, 7 12, and All patients irrespective of previous use were independently reassessed and analyzed blind. Patient Characteristics The IPF group consisted of 27 patients (19 male) with a mean age of 57 yr (range, 26 to 75) (Table 1). The control group consisted of 28 patients (18 male) with a mean age of 54 (range, 21 to 74) (Table 1). The final diagnosis in the control group included: non-small-cell carcinoma (n 9), sarcoidosis (n 9), normal (n 5), chemotherapy-induced fibrosis (n 2), bronchiectasis after tuberculosis (n 1), cystic fibrosis (n 1), extrinsic allergic alveolitis (n 1). Twenty-one of 27 (77%) patients with IPF and 17 of 28 (61%) control subjects were ex-smokers. Sixteen patients with IPF had received immunosuppressive therapy prior to biopsy (Table 2). Immunohistochemistry Sections 5 m thick were cut from formalin-fixed, paraffin-embedded blocks prepared from lung tissue. Sections were first incubated overnight at 4 C in a solution containing 20% (wt/vol) bovine serum albumin to block nonspecific binding of antibodies. Staining for EBV lytic cycle antigens and cellular antigens was then performed using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) according to the manufacturer s instructions and using diaminobenzidine (Sigma Fast; Sigma, St Louis, MO) as substrate. Primary antibodies used were all mouse monoclonal antibodies and included: anti-ebv gp340/220 (clone 72A1), anti-ebv VCA (Mab 817; Chemicon International, Temecula, CA), antihuman cytokeratin (MNF116; Dakopatts, Copenhagen, Denmark) and antisheep MHC Class II antigen (clone VPM36). After immunostaining, sections were counterstained with hematoxylin. The specificities of both of the anti-ebv antibodies were ascertained by reaction against the EBV-positive B-cell line B95-8 and the EBV-negative B-cell line BL41. Both reagents were found to be entirely specific in that they reacted positively with B95-8 and failed to react with BL41. Antisheep MHC Class II is known not to bind to human antigens and was included as a negative control. Samples were randomized and analyzed blind, and the results decoded later. Analysis DNA was extracted from sections 5- m thick that were serially adjacent to those analyzed by IHC using Qiamp tissue kits (Qiagen, Hilden, Germany). Control DNA was extracted from the B-lymphocyte cell lines AM (8) (EBV-positive) and BL41 (9) (EBV-negative). TABLE 1 PATIENT DEMOGRAPHICS Patients with IPF Control Subjects p Value Patients, n Age, yr Male, n/% 19/70 18/ Smokers, n/% 27/77 17/ Definition of abbreviations: IPF idiopathic pulmonary fibrosis. Pilot studies were performed to analyze the ability of extracted DNA to be amplified by using primers specific for the human p53 gene (10). This control yielded a product of 180bp. Amplifiable DNA was best obtained from formalin-fixed lung tissue if proteinase K digestion of the sample was extended from 12 h to 5 d. Amplifiable DNA (100 ng) was subjected to nested analysis using oligonucleotide primers specific for EBV and recombinant Taq DNA polymerase (GIBCO/BRL, Paisley, Scotland, U.K.). The first round of used the primers 5 -GGTCCCGTAGTGACAACTATGCTG and 5 -GAGTGCACCACAGCCAACTCCATG at an annealing temperature of 60 C for 40 cycles as described by Lees and colleagues (11). The second (nested) round of used the primers 5 -GGCTT- TGGGTTCCATTGTGTGC and 5 -TGTACAGAACCAAAGAG- GTGGC at an annealing temperature of 60 C for 25 cycles. products were electrophoresed through 2% agarose gels and DNA visualized by ethidium bromide staining. Molecular weight determinations were made using the 1Kb ladder (GIBCO/BRL). Positive signal for EBV yielded a 284bp product. As for the assay for the P53 gene (above), specificity of the EBV analysis was determined using DNA extracted from EBV-positive (AM) and negative cell lines (BL41). It can be seen in Figure 2 that a positive signal was obtained from EBV-positive cells and no signal was obtained from EBV-negative cells. Thus, the assay was entirely specific for EBV DNA. Limiting dilution of a known amount of cloned target DNA showed that the was sensitive to one copy of EBV DNA. Sections were randomized and analyzed by blind, and the results were decoded afterwards. Statistical Analysis The proportions of patients in each group with positive results were compared using the chi-square test. The probability (p) value is quoted. Significance was set at the 5% level. RESULTS IHC Analysis Lung tissue sections that were positive for EBV by IHC showed positive staining for both gp340/220 and VCA. Conversely, samples negative by IHC showed no staining for either antigen. IHC staining appeared in small, random patches throughout the sections and was present in bronchiolar and alveolar epithelial cells. A representative example of IHC staining is shown in Figure 1. EBV gp340/220 antigen (panel A) was present in cells bordering airways. Panel B is an adjacent serial section and shows that the cells expressing EBV gp340/ 220 were cytokeratin-positive and were therefore epithelial cells. No staining was seen with antisheep MHC class II (panel C) demonstrating the specificity of the positive antibody reactions. Of the patients with IPF, 12 of 27 had EBV-specific staining by IHC compared with three of 28 in the control group (p 0.005). Analysis A representative gel with the products of amplifications from both IPF and control groups are shown in Figure 2. To check the quality of extracted DNA, an aliquot was first amplified by for a control human gene (P53). P53 sequences were amplified from all samples, indicating that the extracted DNA was of sufficient quality for analysis by. A second aliquot of DNA was then analyzed by for the presence of EBV DNA. This showed that 14 of 27 patients with IPF were positive compared with four of 28 control subjects (p 0.007). Comparison of IHC and Assays The results of both analyses are collated and compared in Tables 2, 3, and 4. In the majority, 46 of 55 cases (81%) the assays confirmed the result of the IHC analysis. In a small percentage of cases the IHC and results were not concordant. Samples that were positive by both and IHC were
3 1338 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL Figure 1. IHC analysis of lung section. Adjacent serial sections were stained individually for (A) EBV gp340/ 220, (B) cytokeratin, and (C) sheep MHC Class II.
4 Stewart, Egan, Ross, et al.: Epstein-Barr DNA and IPF 1339 immunosuppression, six were EBV confirmed positive and nine were EBV negative. DISCUSSION Figure 2. analysis of lung sections. DNA was amplified by using primers specific for either the human P53 gene (as a positive control) or EBV. Products were electrophoresed through 2% agarose gels and visualized using a UV transilluminator. Images are shown with the colors reversed for clarity. DNA was amplified from biopsies from patients with IPF (labeled I), control subjects (labeled N), or DNA derived from the B-lymphocyte lines AM (EBV-positive) and BL41 (EBV-negative). identified as confirmed positives. Eleven of the 27 patients with IPF were identified as EBV confirmed positive as compared with none of the 28 control subjects (p 0.001). Three patients with IPF were EBV positive in isolation (IHC negative) and four of the 28 control subjects. Impact of Immunosuppression Analysis of the results in relation to treatment received by patients is shown in Table 5. 57% of patients received immunosuppression. Eight of 14 (57%) patients who were EBV positive had received immunosuppression, whereas eight of 13 (61%) patients who were EBV negative had received immunosuppression (p 0.81). Of 15 patients with IPF receiving The presence of IgA antibodies to EBV VCA has been correlated with a diagnosis of IPF (6). This marker is an indicator of active EBV replication at an epithelial surface. Our previous (7) and current finding of active EBV replication in the lung therefore corroborates the IgA serology, and this study confirms previous immunohistochemical observations (7). EBV antigens and DNA in the lower respiratory tract were significantly associated with a diagnosis of IPF. The assay confirmed IHC staining positive in 45 of 55 cases (81%). With any assay there is a finite number of false positive and negative results. False negative results could have stemmed from extended fixation times or prolonged storage. Fixation of tissue in formalin is detrimental to the quality of both antigen and DNA. An increased fixation time causes excessive crosslinking of protein, a consequent loss of antigenicity, and hence loss of detection by IHC staining. Increased fixation of tissues and storage of blocks also causes greater degradation of DNA, causing a decrease in the ability to detect target sequences by amplification (12). All blocks studied were archived and were of variable (up to 8 yr) age. Variable fixation time and fixatives between tissue blocks may therefore have been factors underlying the discrepancies between samples. Adjacent serial sections of tissue were used for the IHC and assays. The pattern of EBV-specific IHC staining within the lungs suggests a localization of EBV into small, randomly distributed foci (5, 7). Discrepancies between IHC and TABLE 2 PROFILES OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS TABLE 3 PROFILES OF CONTROL PATIENTS Patient No. Age (yr) Smoking Status Drug Treatment IHC for EBV gp340/220 IHC for EBV VCA for EBV Patient No. Age (yr) Diagnosis Smoking Status IHC for EBV gp340/220 IHC for EBV VCA for EBV 1 62 NS 2 62 ES 3 59 ES CycloP, 4 60 ES Az, 5 68 S 6 69 ES 7 61 NS 8 48 ES CyA, 9 60 S CycloP, ES CyA, S ES NS ES CyA S ES Az, NS ES ES ES CycloP, S CycloP, NS CyA, S CycloP NS NS S CycloP, NS Definition of abbreviations: Az azathioprine; CyA cyclosporin A; CycloP cyclophosphamide; EBV Epstein-Barr virus; ES ex-smoker; IHC immunohistochemistry; NS nonsmoker; polymerase chain reaction; Pred prednisolone; S smoker; VCA viral capsid antigen Normal NS 2 55 Normal ES 3 71 NSCLC S 4 74 NSCLC ES 5 70 Fibrosis ES 6 66 EEA NS 7 71 NSCLC ES 8 56 NSCLC S 9 31 CF NS NSCLC ES NSCLC S NSCLC S NSCLC S NSCLC ES Bronchiectasis ES Normal S Normal ES Normal NS Sarcoidosis NS Sarcoidosis NS Sarcoidosis S Sarcoidosis NS Sarcoidosis NS Sarcoidosis ES Sarcoidosis S Sarcoidosis NS Sarcoidosis S Fibrosis NS Definition of abbreviations: CF cystic fibrosis; ES ex-smoker; Fibrosis radiation induced fibrosis; Normal no abnormal diagnosis; NS nonsmoker; NSCLC nonsmall-cell lung cancer; S Smoker. For other definitions, see Table 2.
5 1340 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL TABLE 4 EPSTEIN-BARR VIRUS IMMUNOHISTOCHEMICAL AND RESULTS Group Patients (n) IHC IHC and IHC IHC IHC (n) (%) (n) (%) (n) (%) (n) (%) (n) (%) (n) (%) IPF Control assays could therefore also be due to cells containing EBV in one section being absent in the adjacent serial section or vice versa. The IHC staining and assays used are both EBV-specific. However, each assay measures a distinct biologic facet of EBV infection. EBV exists in either a latent or productively replicating form. In latency there is a restricted pattern of virus gene expression. During productive replication some 60 proteins are produced. The monoclonal antibodies used here were specific for productive cycle proteins and would therefore not detect cells latently infected by EBV. In contrast, the analysis is able to detect latent and productive EBV. Biopsies that were EBV positive by analysis but negative by IHC could therefore have contained latent EBV. B-lymphocytes that contain latent EBV are known to traffic in the blood of all infected persons at a frequency of 1 in to 1 in 10 7 mononuclear cells (13). Because EBV has a seroprevalence of 95% in the age range studied, each group studied might be expected to contain a low number of samples that are positive (14). The precise serologic status of the patients was not available. Such latently infected B-lymphocytes should be negative by IHC. This pattern was identified in six biopsies studied that were positive by but negative by IHC (Table 4). These samples may therefore represent the background of latent EBV normally present in the lung tissue of infected persons. Two recent reports have studied EBV in IPF, one confirming and one conflicting with our findings (15, 16). Wangoo and colleagues (16) were unable to demonstrate specificity of monoclonal antibodies for EBV in lung biopsies. This lack of specificity was not observed either by ourselves in our present or former study or by others (7, 15). The reasons underlying the differing results obtained by Wangoo and colleagues are therefore likely to be technical and related to the reagents used in their study. The inability of Wangoo and colleagues to identify any EBV DNA in lung tissue is perhaps more surprising. Even if EBV were not associated with IPF one would expect to find a low-level background of EBV DNA in lung tissue simply because of the blood volume in this organ. Controls from a study of Human Herpesvirus 8 (HHV-8) in sarcoidosis had a high prevalence of EBV DNA (17). Using described by Wangoo and colleagues (16) one would have expected to identify EBV DNA in some cases. This difference may be rationalized on the basis of difficulty in extraction of DNA from paraffin blocks. In our work, we optimized the DNA extraction procedure from lung tissue and included a positive control for a single-copy human gene (P53). This ensured that each extracted DNA sample was capable of being amplified. Both this study and that of Quddus and colleagues (15), who included an internal amplification control, were able to detect EBV sequences in DNA extracted from lung biopsies obtained from patients with IPF. Wangoo and colleagues did TABLE 5 TREATMENT RECEIVED BY IPF PATIENTS AT THE TIME OF THE SURGICAL PROCEDURE Drugs Immunohistochemistry CyA, CyA, Az, CyA CyA, Cycloph Az, For definition of abbreviations, see Table 2. not include this essential control. It is therefore difficult to assess whether the inability of Wangoo and colleagues to detect EBV DNA was due to genuine absence of EBV sequences or to the lack of amplifiable DNA. Appraisal of patient selection is important in evaluating our results. In the IPF group, no cases of DIP or NSIP were identified by histologic review. This may be explained by the fact that cases of steroid responsive disease (DIP and NSIP) are unlikely to be referred to a tertiary center in the United Kingdom. The control groups predominantly constituted pneumonectomy lung tissue remote from a tumor and sarcoidosis. Our data confirm that of Di Alberti and colleagues (17) who demonstrated that EBV DNA is not detectable in patients with sarcoidosis. However, the rate of EBV positivity was lower in the remainder of our control subjects than in this study. An underestimation of the EBV identified in the control group is unlikely to have occurred as P53 positive controls for DNA extraction was complete for each subject. Recurrent EBV disease may follow immunosuppressive therapy (14). Some patients in this study had received immunosuppression that might have influenced the frequency of EBV detection. Analysis of the data showed that there was no difference in the frequency of EBV detection between patients who received and those who did not receive treatment. However this does not preclude the importance of immunosuppression as a factor in determining the detection of EBV. Samples positive by only one assay may be the result of false positive or false negative reactions. Therefore, absolute positives were considered to be both and IHC positive. The dual assay detection of EBV gave an absolute and statistically significant discrimination between patients with IPF and control subjects. Eleven of 27 (41%) patients with IPF were EBV positive in lung tissue by both assays. It seems likely that this is a true representation of the rate of IPF associated EBV. These data suggest that there may be at least two distinct groups of patients with IPF, those EBV-associated and with the other showing no association with EBV. EBV as cofactor in disease progression may explain why immunosuppression therapy alone has uniformly poor results in patients with IPF. Recent preliminary data suggest that EBV is associated with disease progression (18). Further study is required to determine whether EBV is an important cofactor in disease progression.
6 Stewart, Egan, Ross, et al.: Epstein-Barr DNA and IPF 1341 This study describes an improved method for identifying EBV DNA in lung tissue and confirms an association between EBV and IPF. However, this does not prove a causal relationship between IPF and EBV. To establish whether Herpesviruses are cofactors in patients with IPF, many of whom receive immunosuppression, demands the demonstration of a clinical response to an antiviral agent. The presence of potentially pathogenic viruses in the lung tissue of patients with IPF may explain why immunosuppressive therapy has uniformly poor results in IPF. References 1. Billings, C. G., and P. Howard Hypothesis: exposure to solvents may cause fibrosing alveolitis. Eur. Respir. J. 7: Scott, J., I. Johnston, and J. Britton What causes idiopathic pulmonary fibrosis? A case control study of environmental exposure to dust. Br. Med. J. 301: Egan, J. J., A. A. Woodcock, and J. P. Stewart Viruses and idiopathic pulmonary fibrosis. Eur. Respir. J. 10: Lung, M. L., W. K. Lam, S. Y. So, W. P. Lam, K. H. Chan, and M. H. Ng Evidence that respiratory tract is major reservoir for Epstein- Barr virus. Lancet 1: Egan, J. J., J. P. Stewart, P. S. Hasleton, N. Yonan, P. Bishop, J. R. Arrand, A. N. Rahman, K. B. Carroll, and A. A. Woodcock Epstein-Barr virus associated graft failure following heart/lung transplantation. Thorax 51: Vergnon, J. M., M. Vincent, G. De The, J. F. Mornex, P. Weynets, and J. Brune Idiopathic pulmonary fibrosis and Epstein-Barr virus: an association. Lancet 2: Egan, J. J., J. P. Stewart, P. S. Hasleton, J. R. Arrand, K. B. Carroll, and A. A. Woodcock Epstein-Barr virus replication within pulmonary epithelial cells in idiopathic pulmonary fibrosis. Thorax 50: Wrightam, M. N., J. P. Stewart, N. J. Janjua, S. Pepper, C. Sample, C. M. Rooney, and J. R. Arrand Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208: Lenoir, G. M., M. Vuillaume, and C. Bonnardel The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt s lymphoma. In G. M. Lenoir, G. O Conner, and C. L. M. Olweny, editors. Burkitt s Lymphoma, a Human Cancer Model. IARC Publication, Lyon Gaidano, G., P. Ballerini, J. Z. Gong, G. Inghirami, A. Neri, E. W. Newcomb, I. T. Magrath, D. M. Knowles, and R. Dalla-Favera p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 88: Lees, J. F., A. C. Goodeve, J. E. Arrand, A. K. Ghosh, P. H. Jones, and J. R. Arrand Detection of EBV DNA in post-nasal space biopsy tissue from asymptomatic EBV-seropositive individuals. J. Med. Virol. 37: Greer, C. E., C. M. Wheeler, and M. M. Manos amplification from paraffin-embedded tissues: sample preparation and the effects of fixation. In C. W. Dieffenbach and G. S Dveksler, editors. Primer: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York Decker, L. L., L. D. Klaman, and D. A. Thorley-Lawson Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals. J. Virol. 70: Rickinson, A. B., and E. Kieff Epstein-Barr virus. In B. N. Fields, D. M. Knipe, and P. M. Howley, editors. Fields Virology. Lippincott- Raven, New York Quddus, M. R., A. Nayer, T. C. King, C. L. Jackson, and C. Kuhn EBV in idiopathic pulmonary fibrosis. Lab. Invest. 76: Wangoo, A., R. J. Shaw, T. C. Diss, P. J. Farrell, R. M. du Bois, and A. G. Nicholson Idiopathic pulmonary fibrosis: lack of association with Epstein-Barr virus infection. Thorax 52: Di Alberti, L., A. Piatelli, L. Artese, G. Faina, S. Patel, N. Saunder, S. R. Porter, C. M. Scully, S. L. Ngui, and C. G. Teo Human Herpes- Virus 8 variant in sarcoid tissue. Lancet 350: Tsukamoto, K., H. Hayakawa, A. Sato, T. Suda, K. Chida, and H. Nakamura Epstein-Barr virus latent membrane protein-1 is involved in disease progression in patients with idiopathic pulmonary fibrosis (abstract). Am. J. Respir. Crit. Care Med. 157:A495.
Clinical Study Ganciclovir Antiviral Therapy in Advanced Idiopathic Pulmonary Fibrosis: An Open Pilot Study
Pulmonary Medicine Volume 2011, Article ID 240805, 5 pages doi:10.1155/2011/240805 Clinical Study Ganciclovir Antiviral Therapy in Advanced Idiopathic Pulmonary Fibrosis: An Open Pilot Study J. J. Egan,
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More informationViruses and idiopathic pulmonary fibrosis
Eur Respir J 1997; 10: 1433 1437 DOI: 10.1183/09031936.97.10071433 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 EDITORIAL Viruses and
More information11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective Radiology Pathology Clinical 1 Role of HRCT Diagnosis Fibrosis vs. inflammation Next step in management Response to treatment
More informationCTD-related Lung Disease
13 th Cambridge Chest Meeting King s College, Cambridge April 2015 Imaging of CTD-related Lung Disease Dr Sujal R Desai King s College Hospital, London Disclosure Statement No Disclosures / Conflicts of
More information5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology
Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective No, I am not a pulmonologist! Radiology Pathology Clinical 1 Everyone needs a CT Confidence in diagnosis Definitive HRCT +
More informationNon-neoplastic Lung Disease II
Pathobasic Non-neoplastic Lung Disease II Spasenija Savic Prince Pathology Program Systematic approach to surgical lung biopsies with ILD Examples (chronic ILD): Idiopathic interstitial pneumonias: UIP,
More informationOverview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy
Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy Jeff Swigris, DO, MS Director, ILD Program National Jewish Health Disclosures Speaker - Boehringer Ingelheim and Genentech Objectives Describe
More informationUsual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.
Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia Nitra and the Gangs. บทน ำและบทท ๓, ๑๐, ๑๒, ๑๓, ๑๔, ๑๕, ๑๗ Usual Interstitial Pneumonia (UIP) Most common & basic pathologic pattern
More information4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs
Update in ILDs Diagnosis 101: Clinical Evaluation April 17, 2010 Jay H. Ryu, MD Mayo Clinic, Rochester MN Clinical Evaluation of ILD Outline General aspects of ILDs Classification of ILDs Clinical evaluation
More informationInternational consensus statement on idiopathic pulmonary fibrosis
Eur Respir J 2001; 17: 163 167 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 PERSPECTIVE International consensus statement on idiopathic
More informationEpstein^Barr virus and wild p53 in idiopathic pulmonary brosis
Vol. 95 (2001) 787^791 Epstein^Barr virus and wild p53 in idiopathic pulmonary brosis S. S. LOK*,J.P.STEWART {,B.G.KELLY {,P.S.HASLETON* AND J. J. EGAN* *North West Lung Research Centre and Department
More informationCase Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco
Case Presentations in ILD Harold R. Collard, MD Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Definition/Classification High-resolution CT scan Multidisciplinary
More informationOutline Definition of Terms: Lexicon. Traction Bronchiectasis
HRCT OF IDIOPATHIC INTERSTITIAL PNEUMONIAS Disclosures Genentech, Inc. Speakers Bureau Tadashi Allen, MD University of Minnesota Assistant Professor Diagnostic Radiology 10/29/2016 Outline Definition of
More informationEpidemiology and classification of smoking related interstitial lung diseases
Epidemiology and classification of smoking related interstitial lung diseases Šterclová M. Department of Respiratory Diseases, Thomayer Hospital, Prague, Czech Republic Supported by an IGA Grant No G 1207
More informationDisclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None
Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona
More informationEBV Infection and Immunity. Andrew Hislop Institute for Cancer Studies University of Birmingham
EBV Infection and Immunity Andrew Hislop Institute for Cancer Studies University of Birmingham EBV Introduction Large ds DNA virus Spread by saliva contact Lifelong infection Predominantly B-lymphotropic
More informationNONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP
UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF () FOR PATHOLOGISTS Thomas V. Colby, M.D. Professor of Pathology (Emeritus) Mayo Clinic Arizona FINANCIAL DISCLOSURES NONE OVERVIEW IPF Radiologic Dx Pathologic
More informationProgress in Idiopathic Pulmonary Fibrosis
Progress in Idiopathic Pulmonary Fibrosis David A. Lynch, MB Disclosures Progress in Idiopathic Pulmonary Fibrosis David A Lynch, MB Consultant: t Research support: Perceptive Imaging Boehringer Ingelheim
More informationDiffuse Interstitial Lung Diseases: Is There Really Anything New?
: Is There Really Anything New? Sujal R. Desai, MBBS, MD ESTI SPEAKER SUNDAY Society of Thoracic Radiology San Antonio, Texas March 2014 Diffuse Interstitial Lung Disease The State of Play DILDs Is There
More informationDIAGNOSTIC NOTE TEMPLATE
DIAGNOSTIC NOTE TEMPLATE SOAP NOTE TEMPLATE WHEN CONSIDERING A DIAGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS (IPF) CHIEF COMPLAINT HISTORY OF PRESENT ILLNESS Consider IPF as possible diagnosis if any of the
More informationRestrictive lung diseases
Restrictive lung diseases Restrictive lung diseases are diseases that affect the interstitium of the lung. Interstitium of the lung is the very thin walls surrounding the alveoli, it s formed of epithelium
More informationINTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018
INTERSTITIAL LUNG DISEASE Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018 Interstitial Lung Disease Interstitial Lung Disease Prevalence by Diagnosis: Idiopathic Interstitial
More informationConnective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates
Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates Maria Elena Vega, M.D Assistant Professor of Medicine Lewis Katz School of Medicine at Temple University Nothing to
More informationHerpesviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics
Herpesviruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped icosahedral capsid (T=16), diameter 125 nm Diameter of enveloped virion 200 nm Capsid
More informationFinancial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature
Financial disclosure I have no financial relationships to disclose. Douglas Johnson D.O. Cardiothoracic Imaging Gaston Radiology COMMON DIAGNOSES IN HRCT High Res Chest Anatomy Nomenclature HRCT Sampling
More informationDifferential diagnosis
Differential diagnosis Idiopathic pulmonary fibrosis (IPF) is part of a large family of idiopathic interstitial pneumonias (IIP), one of four subgroups of interstitial lung disease (ILD). Differential
More informationEBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases
Infectious Disease Definitions Infection when a microorganism invades a host and multiplies enough to disrupt normal function by causing signs and symptoms Pathogencity ability of an organism to cause
More informationManish Powari Regional Training Day 10/12/2014
Manish Powari Regional Training Day 10/12/2014 Large number of different types of Interstitial Lung Disease (ILD). Most are very rare Most patients present with one of a smaller number of commoner diseases
More informationVIRUSES AND CANCER Michael Lea
VIRUSES AND CANCER 2010 Michael Lea VIRAL ONCOLOGY - LECTURE OUTLINE 1. Historical Review 2. Viruses Associated with Cancer 3. RNA Tumor Viruses 4. DNA Tumor Viruses HISTORICAL REVIEW Historical Review
More informationExplain the laboratory diagnosis of Rabies?
Explain the laboratory diagnosis of Rabies? The standard test for rabies testing is dfa. This test has been thoroughly evaluated for more than 40 years, and is recognized as the most rapid and reliable
More informationPulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment
Prague, June 2014 Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School,
More informationDiagnostic challenges in IPF
Medicine, Nursing and Health Sciences Diagnostic challenges in IPF Dr Ian Glaspole Central and Eastern Clinical School, Alfred Hospital and Monash University March 2015 Disclosures Consultancy fees from
More informationDetermination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection
Determination of the temporal pattern and importance of BALF1 expression in Epstein-Barr viral infection Melissa Mihelidakis May 6, 2004 7.340 Research Proposal Introduction Apoptosis, or programmed cell
More informationAbsence of Kaposi s Sarcoma-Associated Herpesvirus in Patients with Pulmonary
Online Data Supplement Absence of Kaposi s Sarcoma-Associated Herpesvirus in Patients with Pulmonary Arterial Hypertension Cornelia Henke-Gendo, Michael Mengel, Marius M. Hoeper, Khaled Alkharsah, Thomas
More informationNonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis
Original Article Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparison of the clinicopathologic features and prognosis Xia Li 1, Chang Chen 2, Jinfu Xu 1, Jinming Liu 1, Xianghua
More informationViruses. Poxviridae. DNA viruses: 6 families. Herpesviridae Adenoviridae. Hepadnaviridae Papovaviridae Parvoviridae
Viruses DNA viruses: 6 families Poxviridae Herpesviridae Adenoviridae Hepadnaviridae Papovaviridae Parvoviridae Human herpesviruses Three subfamilies (genome structure, tissue tropism, cytopathologic effect,
More informationDiagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines
Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines Rebecca Keith, MD Assistant Professor, Division of Pulmonary and Critical Care Medicine National Jewish Health, Denver, CO Objectives
More informationLiebow and Carrington's original classification of IIP
Liebow and Carrington's original classification of IIP-- 1969 Eric J. Stern MD University of Washington UIP Usual interstitial pneumonia DIP Desquamative interstitial pneumonia BIP Bronchiolitis obliterans
More informationCase 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar
Case 4 History 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar basilar infiltrates suggestive of pulmonary fibrosis Open
More informationTBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than
TBLB is not recommended as the initial biopsy option in cases of suspected IPF and is unreliable in the diagnosis of rare lung disease (other than PAP) BAL is not required as a diagnostic tool in patients
More informationDIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY?
NIHR Southampton Respiratory Biomedical Research Unit DIFFERENCES IN FIBROPROLIFERATIVE HEALING IN EXOGENEOUS AND IDIOPATHIC ILDs. ARE THERE ANY? Fibrosing Interstitial Lung Diseases CPFS/WASOG/AIPO/ERS
More informationBronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy
Idiopathic Pulmonary Fibrosis Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy JMAJ 46(11): 469 474, 2003 Yukihiko SUGIYAMA Professor, Division of Pulmonary Medicine, Department of
More informationEpstein-Barr Virus: Cell Trafficking Is Crucial for Persistence
Epstein-Barr Virus: Cell Trafficking Is Crucial for Persistence This virus moves between host lymphoid and epithelial cells, switching its tropism while enhancing persistence Lindsey Hutt-Fletcher Herpesviruses,
More informationA Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco
A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Outline Overview of diagnosis in ILD Why it is important Definition/Classification
More informationEpstein-Barr Virus 1
Epstein-Barr Virus 1 Herpesviruses dsdna, linear, enveloped, 180-200 nm Large genome, codes for 75 viral proteins 50-70% similarity Cross reactivity between HSV and VZV HSV-2 virus particle. Note that
More information2017 CST-Astellas Canadian Transplant Fellows Symposium. EBV Post Transplantation Implications and Approach to Management
2017 CST-Astellas Canadian Transplant Fellows Symposium EBV Post Transplantation Implications and Approach to Management Atul Humar, MD Atul Humar is a Professor in the Department of Medicine, University
More informationEpstein-Barr Virus: Stimulation By 5 '-Iododeoxy uridine or 5 '-Brom odeoxy uridine in Human Lymphoblastoid Cells F ro m a Rhabdom yosarcom a*
A n n a ls o f C l i n i c a l L a b o r a t o r y S c i e n c e, Vol. 3, No. 6 Copyright 1973, Institute for Clinical Science Epstein-Barr Virus: Stimulation By 5 '-Iododeoxy uridine or 5 '-Brom odeoxy
More informationEBV infection B cells and lymphomagenesis. Sridhar Chaganti
EBV infection B cells and lymphomagenesis Sridhar Chaganti How EBV infects B-cells How viral genes influence the infected B cell Differences and similarities between in vitro and in vivo infection How
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Idiopathic Pulmonary Fibrosis Page 1 of 10 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Idiopathic Pulmonary Fibrosis (Esbriet /pirfenidone, Ofev /nintedanib)
More informationA Review of Interstitial Lung Diseases
Outline A Review of Interstitial Lung Diseases Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco Overview of diagnosis in ILD Why it is important Definition/Classification
More informationImaging: how to recognise idiopathic pulmonary fibrosis
REVIEW IDIOPATHIC PULMONARY FIBROSIS Imaging: how to recognise idiopathic pulmonary fibrosis Anand Devaraj Affiliations: Dept of Radiology, St George s Hospital, London, UK. Correspondence: Anand Devaraj,
More informationHerpesvirus DNA Is Consistently Detected in Lungs of Patients with Idiopathic Pulmonary Fibrosis
JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p. 2633 2640 Vol. 41, No. 6 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.6.2633 2640.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationYamaguchi University School of Medicine, Kogushi, Ube, Yamaguchi. growth in low serum, anchorage-independent growth in soft
JOURNAL OF VIROLOGY, Sept. 1994, p. 6069-6073 Vol. 68, No. 9 0022-538X/94/$04.00+0 Copyright 1994, American Society for Microbiology Isolation of Epstein-Barr Virus (EBV)-Negative Cell Clones from the
More informationLines and crackles. Making sense of ILD
Lines and crackles Making sense of ILD Case JM 65 year old male Gradual shortness of breath, going on over a year Some dry cough Ex-smoker, quit 10 years ago Crackles in the bases CXR presented Sent to
More informationFollicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients
Respiratory Medicine (2008) 102, 307 312 Follicular bronchiolitis in surgical lung biopsies: Clinical implications in 12 patients Michelle R. Aerni a, Robert Vassallo a,, Jeffrey L. Myers b, Rebecca M.
More informationIPF: Epidemiologia e stato dell arte
IPF: Epidemiologia e stato dell arte Clinical Classification Diffuse parenchimal lung diseases Exposure-related: - occupational - environmental - medication Desquamative interstitial pneumonia Idiopathic
More informationA CONTRIBUTION TO THE ETIOPATHOGENESIS, DIAGNOSIS AND MANAGEMENT OF SINONASAL INVERTED PAPILLOMAS
UNIVERSITY OF MEDICINE AND PHARMACY OF TÂRGU MUREȘ ROMANIA A CONTRIBUTION TO THE ETIOPATHOGENESIS, DIAGNOSIS AND MANAGEMENT OF SINONASAL INVERTED PAPILLOMAS PhD THESIS ABSTRACT PhD Student Viorel Emanoil
More informationPersistent Infections
Persistent Infections Lecture 17 Biology 3310/4310 Virology Spring 2017 Paralyze resistance with persistence WOODY HAYES Acute vs persistent infections Acute infection - rapid and self-limiting Persistent
More informationSurvival in Patients With Cryptogenic Fibrosing Alveolitis*
Survival in Patients With Cryptogenic Fibrosing Alveolitis* A Population-Based Cohort Study Richard Hubbard, DM; Ian johnston, MD; and john Britton, MD Study objectives: To determine the median survival
More informationLab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) MIC AMAL ALGHAMDI 1
Lab 3: Pathogenesis of Virus Infections & Pattern 450 MIC PRACTICAL PART SECTION (30397) 2018 450 MIC AMAL ALGHAMDI 1 Learning Outcomes The pathogenesis of viral infection The viral disease pattern Specific
More informationPathologic Assessment of Interstitial Lung Disease
Pathologic Assessment of Interstitial Lung Disease Dry and itchy? It could be eczema or fungal infection. We don t need to worry, the drugs aren t that dangerous. Kirk D. Jones, MD UCSF Dept. of Pathology
More informationNanoparticles and persistent virus infection a dangerous liaison for the development of chronic lung disease(s)? Tobias Stöger
Nanoparticles and persistent virus infection a dangerous liaison for the development of chronic lung disease(s)? Tobias Stöger Herpesviruses and lung disease Double-stranded DNA-viruses (a, b, g- herpesviruses)
More informationIn idiopathic pulmonary fibrosis (IPF) and
Eur Respir J 2010; 35: 830 835 DOI: 10.1183/09031936.00155108 CopyrightßERS Journals Ltd 2010 Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
More informationCOI: no conflicts of interest to declare
Idiopathic versus secondary Usual Interstitial Pneumonia (UIP) pattern in a series of 96 consecutive surgical lung biopsies: The value of histologic ancillary findings in a multidisciplinary discussion
More informationUnpaid scientific collaborator & advisor with Veracyte, Inc.
Diagnosis and Classification of Idiopathic Interstitial Pneumonias: Role of Histopathology in the Golden Age of Consensus Jeffrey L. Myers, M.D. A. James French Professor of Diagnostic Pathology Vice Chair
More informationTITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer
AD Award Number: W81XWH-04-1-0579 TITLE: CYP1B1 Polymorphism as a Risk Factor for Race-Related Prostate Cancer PRINCIPAL INVESTIGATOR: Yuichiro Tanaka, Ph.D. CONTRACTING ORGANIZATION: Northern California
More informationEpstein-Barr Virus (EBV) Infection in Epithelial Cells In Vivo: Rare Detection of EBV Replication in Tongue Mucosa but Not in Salivary Glands
BRIEF REPORT Epstein-Barr Virus (EBV) Infection in Epithelial Cells In Vivo: Rare Detection of EBV Replication in Tongue Mucosa but Not in Salivary Glands Phroso Frangou, Maike Buettner, and Gerald Niedobitek
More informationINTERSTITIAL LUNG DISEASE Dr. Zulqarnain Ashraf
Indep Rev Jul-Dec 2018;20(7-12) Dr. Zulqarnain Ashraf IR-653 Abstract: ILD is a group of diseases affect interstitium of the lung. Repeated insult to the lung cause the interstitium to be damaged. Similarly
More informationHypersensitivity Pneumonitis: Epidemiology and Classification
Hypersensitivity Pneumonitis: Epidemiology and Classification Ulrich Costabel, MD University of Duisburg-Essen, Ruhrlandklinik Department of Pneumology/Allergy Objectives Definitions, Etiology Epidemiology
More informationSee external label 2 C-8 C Σ=96 tests Cat # EBV-VCA IgA. Cat # EBV -VCA IgA ELISA. ELISA: Enzyme Linked Immunosorbent Assay
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationPREVALENCE AND ACTIVITY OF HERPESVIRUSES IN APICAL PERIODONTITIS. by Katinka Hernádi, D.M.D. Supervisor: József Kónya, M.D., Ph.D.
SHORT THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PH.D.) PREVALENCE AND ACTIVITY OF HERPESVIRUSES IN APICAL PERIODONTITIS by Katinka Hernádi, D.M.D Supervisor: József Kónya, M.D., Ph.D. UNIVERSITY OF
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationEBV Infection. > Cellular Immune Response Profiling. > Humoral Immune Response Profiling EBV. ImmunoTools
EBV ImmunoTools Peptide Tools to Study EBV EBV Infection > Cellular Immune Response Profiling Antigen spanning EBV PepMix Peptide Pools PepMix Collection EBV > Humoral Immune Response Profiling EBV RepliTope
More informationMedical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses
Medical Virology Lecture 2 Asst. Prof. Dr. Dalya Basil Herpesviruses, Orthomyxoviruses, and Retro virus - Herpesviruses Structure & Composition: Herpesviruses Enveloped DNA viruses. All herpesviruses have
More informationEndobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer
Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer Dr Richard Booton PhD FRCP Lead Lung Cancer Clinician, Consultant Respiratory Physician & Speciality Director Manchester University NHS
More informationIPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK?
IPF AND OTHER FIBROSING LUNG DISEASE: WHAT DRUGS MIGHT WORK AND ON WHOM DO THEY W ORK? KEVIN K. BROWN, MD PROFESSOR AND VICE CHAIRMAN, DEPARTMENT OF MEDICINE NATIONAL JEWISH HEALTH DENVER, CO Kevin K.
More informationAccumulation of periostin in acute exacerbation of familial idiopathic pulmonary fibrosis
Case Report Accumulation of periostin in acute exacerbation of familial idiopathic pulmonary fibrosis Keisuke Murata 1, Yasuhiko Koga 1, Norimitsu Kasahara 1, Yoshimasa Hachisu 1, Satoshi Nunomura 2, Nozomi
More informationPatient with FVC>90% predicted. Demosthenes Bouros, Vasilios Tzilas University of Athens
Patient with FVC>90% predicted Demosthenes Bouros, Vasilios Tzilas University of Athens CASE OVERVIEW A 63-year-old, male patient with progressive exertional dyspnoea lasting for 2 years and dry cough
More informationReplacement of air with fluid, inflammatory. cells or cellular debris. Parenchymal, Interstitial (Restrictive) and Vascular Diseases.
Parenchymal, Interstitial (Restrictive) and Vascular Diseases Alain C. Borczuk, M.D. Dept of Pathology Replacement of air with fluid, inflammatory cells Pulmonary Edema Pneumonia Hemorrhage Diffuse alveolar
More informationPediatric High-Resolution Chest CT
Pediatric High-Resolution Chest CT Alan S. Brody, MD Professor of Radiology and Pediatrics Chief, Thoracic Imaging Cincinnati Children s s Hospital Cincinnati, Ohio, USA Pediatric High-Resolution CT Short
More informationCommon things are common, but not always the answer
Kevin Conroy, Joe Mackenzie, Stephen Cowie kevin.conroy@nhs.net Respiratory Dept, Darlington Memorial Hospital, Darlington, UK. Common things are common, but not always the answer Case report Cite as:
More informationPatient with IPF and no honeycombing on HRCT. Case 1 Demosthenes Bouros, Vasilios Tzilas University of Athens
Patient with IPF and no honeycombing on HRCT Case 1 Demosthenes Bouros, Vasilios Tzilas University of Athens CASE OVERVIEW A 76-year-old male patient presented with progressive exertional dyspnoea refractory
More informationElevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis.
Eur Respir J 1997; 10: 2040 2045 DOI: 10.1183/09031936.97.10092040 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Elevation of antibodies
More informationCombined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases
CASE REPORT Combined Unclassifiable Interstitial Pneumonia and Emphysema: A Report of Two Cases Nobuhiko Nagata 1, Kentaro Watanabe 2, Michihiro Yoshimi 3, Hiroshi Okabayashi 4, Katsuo Sueishi 5, Kentaro
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More informationOTKA azonosító: Típus: K Vezető kutató: Gergely Lajos
Human herpesvirus 6 (HHV-6), mostly variant B reactivation in renal transplant patients has been published previously, but the pathogenetic role of HHV-6 variant A has not been clarified. During the project
More informationHypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas
Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas Rishi Raj MD Director, Interstitial Lung Diseases Program Clinical Professor of Pulmonary and Critical Care Medicine Stanford University
More informationRadiologic Approach to Smoking Related Interstitial Lung Disease
Radiologic Approach to Smoking Related Interstitial Lung Disease Poster No.: C-1854 Congress: ECR 2013 Type: Educational Exhibit Authors: K.-N. Lee, J.-Y. Han, E.-J. Kang, J. Kang; Busan/KR Keywords: Toxicity,
More informationCareful histopathological evaluation has shown the traditionally clinical diagnosis of
Demystifying Idiopathic Interstitial Pneumonia Harold R. Collard, MD; Talmadge E. King, Jr, MD REVIEW ARTICLE Careful histopathological evaluation has shown the traditionally clinical diagnosis of idiopathic
More informationCase Report Traumatic Haemorrhagic Cervical Lymphadenopathy with Underlying Infectious Mononucleosis
Hindawi Case Reports in Radiology Volume 2017, Article ID 3097414, 4 pages https://doi.org/10.1155/2017/3097414 Case Report Traumatic Haemorrhagic Cervical Lymphadenopathy with Underlying Infectious Mononucleosis
More informationLung Allograft Dysfunction
Lung Allograft Dysfunction Carlos S. Restrepo M.D. Ameya Baxi M.D. Department of Radiology University of Texas Health San Antonio Disclaimer: We do not have any conflict of interest or financial gain to
More informationThe Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page
The Egyptian Journal of Hospital Medicine (July 2017) Vol.68 (2), Page 1135-1140 Role of High Resolution Computed Tomography in Diagnosis of Interstitial Lung Diseases in Patients with Collagen Diseases
More informationGammaherpesviruses have clinical relevance in both the
Lung Epithelial Cells Are a Major Site of Murine Gammaherpesvirus Persistence By James P. Stewart, Edward J. Usherwood, Alan Ross, Heather Dyson, and Tony Nash From the Department of Veterinary Pathology,
More informationIPF - Inquadramento clinico
IPF - Inquadramento clinico Sergio Harari Unità Operativa di Pneumologia UTIR Servizio di Fisiopat. Resp. e Emodinamica Polmonare Ospedale S. Giuseppe, Milano Clinical Classification Diffuse parenchimal
More informationCytomegalovirus (CMV) End-Point PCR Kit Product# EP36300
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Cytomegalovirus (CMV) End-Point PCR Kit Product# EP36300 Product
More informationUIP Possibile e Probabile
UIP Possibile e Probabile Sergio Harari U.O. di Pneumologia e UTIR Servizio di Emodinamica e Fisiopatologia Respiratoria Ospedale San Giuseppe - Milano Current definition of IPF IPF is a distinct type
More informationValidation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1
I. Objectives Validation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1 1. To ensure stability of RNA (highly thermolabile and degradatively
More information